Publications by authors named "Savita Bakhshi Anand"
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study.
J Int Assoc Provid AIDS Care
September 2024
Introduction: CARISEL is an implementation-effectiveness "hybrid" study examining the perspectives of people living with HIV-1 (patient study participants [PSPs]) on cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) dosed every 2 months (Q2M) across 5 European countries.
Methods: PSPs completed questionnaires on acceptability (Acceptability of Intervention Measure), appropriateness (Intervention Appropriateness Measure), and feasibility (Feasibility of Intervention Measure) at their first (Month [M] 1), third (M4), and seventh (M12) injection visits. Semistructured qualitative interviews were also conducted.
Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations.
J Int AIDS Soc
July 2024
Article Synopsis
- Cabotegravir plus rilpivirine (CAB+RPV) is a long-acting HIV treatment being studied for its implementation effectiveness in European clinics through the CARISEL study.
- The study involved 18 clinics that were divided into two groups: one received standard support, while the other got enhanced support that included more training and team meetings.
- Staff participants (SSPs) reported high acceptability, appropriateness, and feasibility scores for CAB+RPV throughout the year, indicating positive feedback on its implementation, with no significant differences noted between the two support groups.
Objective: To evaluate the impact of uterine fibroid symptoms on employment and household productivity.
Methods: An online survey of US women between 18 and 54 was conducted. Productivity was assessed using the health related productivity questionnaire (HRPQ).